Navigation Links
DrugRisk Announces New Pradaxa Health Warning From Australia
Date:1/5/2013

Orlando, FL (PRWEB) January 05, 2013

The prescription drug resource center DrugRisk.com has added new information to its already comprehensive database for the blood thinner Pradaxa, after an Australian health advisory questioned whether the drug was safe enough for the government to supply it to citizens.

“DrugRisk’s goal is to improve patient safety through education with the latest drug warnings, recalls, studies and litigation news. Although most people never hear about drug warnings from other countries, these can be just as important as those in the U.S.,” explained DrugRisk representative Ryan Mayer.

Last month, Australia’s Pharmaceutical Benefits Advisory Committee (PBAC) warned that they may withdraw recommendations that the government continue to furnish prescriptions of Pradaxa.*

The Committee noted concerns that, while Pradaxa may have health and financial benefits over other anticoagulants, it may be prescribed for patients and at dosages not tested in clinical trials.

In the United States, experts disagree about the safety of Pradaxa bleeding risks. Last month the FDA updated warnings to say the drug carries the same risks as warfarin.** However, the New York Times also reported doctors’ concerns that Pradaxa led all medications for adverse reports and currently has no antidote for internal bleeding.***

Most common among the adverse reports were 6497 gastrointestinal side effects, 4910 gastrointestinal hemorrhages (bleeding) and 2941 central nervous system or cranial hemorrhaging problems. There were also 842 deaths attributed to the drug.****

Since September, the number of patients filing a Pradaxa lawsuit over internal bleeding has risen 50%.***** The cases have now been moved to a special federal court in Illinois, formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Anyone affected by internal bleeding after Pradaxa use is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of federal drug injury cases, the Drug Risk Resource Center only recommends lawyers who are already handling Pradaxa lawsuits.

For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*pharmatimes.com/Article/12-12-20/Australia_warning_over_Pradaxa_PBS_listing.aspx
**fda.gov/Drugs/DrugSafety/ucm332912.htm***fda.gov/Drugs/DrugSafety/ucm326580.htm
***nytimes.com/2012/11/03/business/a-rising-anti-stroke-drug-is-tied-to-risk-of-bleeding-deaths.html
****adverseevents.com/drugdetail.php?AEDrugID=1067&BrandName=PRADAXA
*****jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets-By-District-November-2012.pdf

Read the full story at http://www.prweb.com/releases/pradaxa-internal/bleedings-risks/prweb10290093.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
2. DrugRisk Announces Updated Information on Mirena Lawsuits
3. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
4. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
5. The Life Support Technologies Group Announces 2013 Hyperbaric Medical Training Course Dates
6. Barton Associates Announces OB/GYN Locum Tenens Staffing Group
7. PCH Mutual Insurance CO., A RRG Announces Dividend for 2013
8. CoachingWebsites (Websites for Coaches) Announces a New Scheduling Calendar Feature for Coaches in 2013
9. Footwear etc. Announces the New Spring Collection from Orthaheel
10. Nutrisystem Announces Latest Weight Loss Success Story: Long Beach Husband and Wife Drop a Combined Total of 46 Pounds; Plus, Expert Dieting Tips for Couples
11. PMD Healthcare Announces how Spiro PD Personal Spirometer Supports New Year’s Resolution to Exercise and Lose Weight, Complementing ACAAI Recommendations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental ... Your Mouth?” (WIYM) campaign to inform dentists and patients about the safety issues related ... and prosthetic market in the U.S. is projected to reach $6.4 billion in 2018 ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... was set up in 2006 as a non-profit organization to unite pharmaceutical and ...
(Date:12/8/2016)... ... 08, 2016 , ... Healthcare is in flux. The GOP ... the mass media launching of story movements to highlight what's most unfair about ... experiences; such a movement can generate the network power to improve healthcare policies ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp Insurance, an ... around the greater Phoenix metropolitan region, is announcing a charity event to provide ... the Homeless Youth Connection is to promote community awareness of the ongoing needs ...
(Date:12/7/2016)... ... 07, 2016 , ... DrugDev again demonstrated its dedication to reducing ... the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department of Commerce. ... sides of the Atlantic with a mechanism to comply with EU data protection requirements ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016   TriNetX , the health research ... signed a membership agreement to join the ... new cures. The TriNetX network is ... patients globally, biopharmaceutical companies and contract research organizations ... design, site selection, patient recruitment, and collaborative research ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals International, ... VRX) ("Valeant") today announced positive results from a ... to assess the safety and efficacy of IDP-118 ... of plaque psoriasis. Within the ... moderate to severe psoriasis, IDP-118 showed statistical significance ...
(Date:12/8/2016)... 8, 2016  EIP Pharma, LLC ( www.eippharma.com ... for neflamapimod (previously code named VX-745), with the ... trials that demonstrated significant Alzheimer,s disease relevant pharmacological ... and Study 303 (6-week treatment) are the subject ... Disease (CTAD) scientific conference in San ...
Breaking Medicine Technology: